CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of NA-831 in Alzheimer Patients With Mild Cognitive Impairment

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03538522
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:39.855259+00:00
Published At: 2020-06-30T00:00:00+00:00
Record Updated At: 2020-06-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Mild Cognitive Impairment", "Alzheimer Disease", "Alzheimer Dementia", "Dementia, Vascular", "Dementia With Lewy Bodies", "Cognitive Impairment", "Tauopathies", "Neurodegenerative Diseases", "Neurocognitive Disorders", "Cognitive Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-06-30"
protocolSection.identificationModule.nctId: "NCT03538522"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of NA-831 in Alzheimer Patients With Mild Cognitive Impairment"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.